Needham & Co lifted theier price targete on Dyax Corp. (Nasdaq: DYAX) to $8 from $6, following FDA approval of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE